Unable to extract actionable details due to unreadable images. Monitor for a definitive proxy statement or subsequent filings that may clarify the voting items. Given the company's poor historical stock performance following past filings, exercise caution.
ARVN drugs
ARVN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 29 $9.82entry
- T+1 · 7mo ago +0.81%α −0.21% · $9.90
- T+5 · 7mo ago +8.04%α +4.93% · $10.61
- T+20 · 6mo ago −9.88%α −15.34% · $8.85
- T+60 · 4mo ago −18.23%α −22.34% · $8.03
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Arvinas filed additional definitive proxy soliciting materials (DEFA14A) on April 29, 2026. The actual content consists of images that could not be parsed, so the specific matters being solicited are unclear. This is a routine procedural filing with no discernible financial impact.
Key Facts
- Filing type: DEFA14A (additional definitive proxy materials)
- Filed by registrant (management) on April 29, 2026
- Document content is image-based and not machine-readable
Financial Impact
Not specified
Risk Factors
- Material terms of proxy solicitation are unknown
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001628280-26-028158 |
| Document: 0001628280-26-028158-index-headers.html | 0001628280-26-028158 |
| Document: 0001628280-26-028158-index.html | 0001628280-26-028158 |
| Document: 0001628280-26-028158.txt | 0001628280-26-028158 |
Track record
21 reports on ARVN
6 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +28.62% at T+60 after the Feb 23, 2026 report. 9 of 9 went positive at some point.
Filters
- Nov 3, 202613d ago S-3 Bearish 5/10 Entry $7.42 to $6.55 Now $6.77 +8.76% ▲ +11.73% +7.32% vs SPY
- Nov 3, 202613d ago 8-K Bearish 5/10 No price data
- Nov 3, 202613d ago Press Release Neutral 4/10 Entry $7.09 to $7.42 Now $6.77 −4.51% ▲ +4.65% +3.00% vs SPY
- Sep 4, 202610w ago 144 Neutral 3/10 Entry $9.08 to $8.76 Now $6.77 −25.44% ▼ −3.52% −3.06% vs SPY
- Jun 22, 202621w ago 8-K Neutral 3/10 Entry $8.14 to $8.05 Now $6.77 −16.83% ▼ −1.11% −1.06% vs SPY
- Jun 2, 202623w ago 8-K Bearish 6/10 Entry $7.70 to $7.74 Now $6.77 +12.08% ▼ −0.52% −0.12% vs SPY
- May 12, 202626w ago 8-K Mixed 6/10 No price data
- May 12, 202626w ago 8-K Bullish 7/10 Entry $9.57 to $9.87 Now $6.77 −29.26% ▲ +3.13% +2.56% vs SPY
- May 12, 202626w ago Press Release Bearish 8/10 Entry $9.57 to $9.87 Now $6.77 +29.26% ▼ −3.13% −2.56% vs SPY
- May 8, 202627w ago 144 Neutral 2/10 Entry $9.66 to $9.57 Now $6.77 −29.92% ▼ −0.93% −0.80% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers